3002-94-6Relevant articles and documents
NMR spectrocopy of organolithium compounds, part XXXIV: Cyclopropyllithium and lithium bromide (1:1) in diethylether/tetrahydrofuran—Identification of a fluxional mixed tetramer
Eppers, Oswald,Günther, Harald
, p. 131 - 138 (2020)
Cyclopropyllithium, C3H5Li (1), was studied in the presence of one equivalent lithium bromide (LiBr) in diethylether (DEE)/tetrahydrofuran (THF) mixtures and in THF as solvents. Increasing the THF concentration in DEE/THF leads in the 6Li NMR spectrum to a main signal (S1) at δ0.85 (rel. to ext. LiBr/THF) and a second resonance (S2) at δ0.26 aside from a minor component at δ0.07. In pure THF, the ratio of these signals was 66: 28:6. 6Li and 13C NMR allowed to identify the main signal as belonging to a mixed dimer, 1?LiBr, and the signal at 0.26 ppm to a fluxional mixed tetramer, 12?(LiBr)2. 1J(13C,6Li) coupling constants of 11.0 and 9.8 Hz were measured at 168 K for S1 and S2, respectively, and chemical exchange between both signals was detected by 2D 6Li,6Li exchange spectroscopy and analyzed by temperature-dependent 1D 6Li line-shape calculations. These yielded the equilibrium constants Keq for the chemical exchange Li4(C3H5)2Br2 ? 2 Li2C3H5Br. Their temperature dependence leads to van't Hoff parameters of ΔH° = 4.6 kJ/mol, ΔS° = 41.4 J/mol K, and ΔG°298 = ?7.8 kJ/mol. From the rate constants k, Eyring parameters of ΔH* = 42.0 kJ/mol, ΔS* = 33.0 J/mol K, and ΔG* 298 = 32.2 kJ/mol were calculated for the forward reaction Li4(C3H5)2Br2 → 2 Li2C3H5Br and ΔH* = 37.5 kJ/mol, ΔS* = ?8.4 J/mol K, and ΔG* 238 = 40.0 kJ/mol for the reverse reaction 2Li2C3H5Br → Li4(C3H5)2Br2.
CONDENSED IMIDAZOLE DERIVATIVES SUBSTITUTED BY TERTIARY HYDROXY GROUPS AS PI3K-GAMMA INHIBITORS
-
Page/Page column 233, (2019/05/10)
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-y which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Glycomimetic replacements for hexoses and N-acetyl hexosamines
-
Page/Page column 24, (2008/12/06)
Compounds and methods are provided for obtaining oligosaccharide mimics. More specifically, compounds and methods are described wherein oligosaccharide mimics are obtained by incorporating or substituting in a cyclohexane derivative.